Navigation Links
Hepatitis C Occurs Even After Liver Transplantation

The serum viral levels fall after the removal of a diseased liver from a Hepatitis C (HCV) patient. Virus levels are found to return even after a healthy liver transplant, which can even go beyond pre-transplant levels, // according to a new research results published in the American Association for the Study of Liver Diseases’ (AASLD) Liver Transplantation journal. The chief reason for most liver transplantations is Hepatitis C.

As many as six liver transplant patients who had undergone cadaveric liver transplants as result of HCV infection were studied by the team of researchers. The levels of the HCV RNA were measured for changes with blood tests before, during and after the transplant operation utilizing the reverse transcription polymerase chain reaction assay, and linear regression was used to analyze the results.

It was seen that the HCV RNA levels fell in the case of most patients during the course of the transplantation operation, which rose subsequently afterwards, until a level which is above the pre-transplantation level is attained, in some cases growing by 100% every 2 days.

In the case of three patients there was a plateauing of the level before rising. As much as 4% of the viral production is from non-hepatic sources, while the liver accounts for the balance 96%, which goes to prove that the primary viral replication takes place in the liver. The virion half-life seen in this study is very much higher than what has been observed in previous studies, even though the rise and fall of the viremia appears to be the same.
'"/>




Page: 1

Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Cure for Hepatitis B
4. Hepatitis E virus made impotent
5. Sharing injection equipment spreads Hepatitis C
6. Lymphomas Link to Hepatitis C
7. Hepatitis shots is promising
8. Need for Hepatitis Booster Questioned
9. Good News for HIV Patients Also Suffering From Hepatitis C Virus
10. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
11. The Effectiveness Of Hepatitis B Vaccine Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss ... WE TV’s “Mama June: From Not to Hot,” which will begin airing on February ... Shannon, known to millions from the 2012 reality television series, “Here Comes Honey Boo ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... host a diverse symposium on “Doping in Sport: How the Culture Might ... Richter & Hampton LLP. The symposium will be held at Pepperdine University in ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 23, 2017  The particle counters market is ... from USD 275.9 million in 2016, at a ... report: http://www.reportlinker.com/p04718602-summary/view-report.html The growing ... R&D, and growth in manufacturing industries in emerging ... for particle counters. On the other hand, technical ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... CITY, Calif., Feb. 23, 2017 Nevro Corp. (NYSE: ... evidence-based solutions for the treatment of chronic pain, today reported ... December 31, 2016. 2016 Accomplishment & Highlights: ... full year 2016, an increase of 228% as reported, over ... for 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology: